RB Global Operating Cash Flow decreased by 12.2% to $224.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.9%, from $156.80M to $224.10M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 32.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.70M | $92.73M | $13.48M | $185.10M | $12.90M | $65.90M | $199.20M | -$57.30M | $107.20M | $156.80M | $337.30M | $124.80M | $337.30M | $285.40M | $184.50M | $156.80M | $326.50M | $239.70M | $255.20M | $224.10M |
| QoQ Change | — | +202.1% | -85.5% | >999% | -93.0% | +410.9% | +202.3% | -128.8% | +287.1% | +46.3% | +115.1% | -63.0% | +170.3% | -15.4% | -35.4% | -15.0% | +108.2% | -26.6% | +6.5% | -12.2% |
| YoY Change | — | — | — | — | -58.0% | -28.9% | >999% | -131.0% | +731.0% | +137.9% | +69.3% | +317.8% | +214.6% | +82.0% | -45.3% | +25.6% | -3.2% | -16.0% | +38.3% | +42.9% |